Menu Back toSession 1 Track 2: Current and Emerging Technologies

Digital Technology in Clinical Trials

This event is now offered in a new entirely virtual format.


Session 1 Track 2: Current and Emerging Technologies

Session Chair(s)

Keith  Wenzel

Keith Wenzel

  • Senior Director, Scientific Data Organization
  • Parexel International, United States
Despite being a risk adverse industry, the Life Sciences Industry currently has a stable of tried and true technologies which have been embraced and generate value, but we find ourselves beset by literal barrage of new technologies some of which show signs of promise, some where the jury is still out and others yet untested, but intriguing. This session will include two presentations on Current and Emerging Technologies followed by a panel discussing the state of play for digital technology and the trends and concepts around the next generation of tried and true technologies as well as the potential benefits of emerging technology.
Learning Objective :

At the conclusion of this session, participants should be able to:

  • Understand how currently accepted and adopted technology is evolving to deliver additional benefits
  • Have a view to emerging technologies and their respective place along the adoption curve

Speaker(s)

Stephen  Ruhmel, MPH

Speaker

Stephen Ruhmel, MPH

  • Clinical Innovation Lead
  • Janssen Research & Development, United States
Keith  Wenzel

Speaker

Keith Wenzel

  • Senior Director, Scientific Data Organization
  • Parexel International, United States
Paul  Upham

Panelist

Paul Upham

  • Head, Smart Devices
  • Roche / Genentech, United States
Bill  Byrom, PhD

Bill Byrom, PhD

  • Vice President, Product Intelligence and Positioning
  • Signant Health , United Kingdom